Projects
Approved TransSCOT projects:
| TransSCOT Number | Title | PI | Status | Publication |
|---|---|---|---|---|
| 1 | Investigating molecular markers in samples collected from patients with colorectal cancer | David Church (Oxford), Iain Tomlinson (Edinburgh), Owen Samson (Glagsow) | in progress | pending |
| 4 | Tumour budding as a predictor of response and survival in colorectal cancer | Viktor Koelzer (Zurich) | analysis phase | in progress |
| 5 | Colorectal cancer phenotypic subtypes as a predictor of response to therapy | Joanne Edwards (Glasgow) | complete | |
| 7 | Immunoscore of colorectal cancer | Halio Dx (France) | analysis phase | in progress |
| 8 | Image-based transciptional classification of colorectal tumours as predictor of repsonse and survival in colorectal cancer | Viktor Koelzer (Zurich), Tim Maughan (OXford), Jens Rittscher (Oxford) | complete | in progress |
| 12 | In silico pathology, large scale genomic instability and new prognostic biomarkers in colorectal cancer | Havard Danielsen (Norway) | in progress | pending |
| 13 | Genomic analysis of the tumour and its microenvironment to predict response in adjuvant chemotherapy in colon cancer | Campbell Roxburgh (Glasgow) | in progress | pending |
| 17 | Prediction of microsatellite status, BRAF Status and overall survival in colorectal cancer directly from histology with deep learning | Jakub Kather (Germany) | analysis phase | in progress |
| 18 | Mismatch repair deficiency in colorectal cancer | David Church (Oxford) | analysis phase | in progress |
| 19 | IKKα as a potential novel target for treatment in colorectal cancer | Joanne Edwards (Glasgow) | analysis phase | in progress |
| 20 | Identification of metabolic signatures which define therapeutic efficacy in colorectal cancer | Andrew Campbell (Glasgow) | analysis phase | in progress |
| 24 | Determining prognosis value of phosphorylated STAT3(705) expression in patients undergoing different chemotherapeutic regimes in colorectal cancer | Joanne Edwards (Glasgow), Kathryn Pennel (Glasgow) | analysis phase | in progress |
| 25 | Molecular determinats of anti-tumour immune response and clinical outcomes in colorectal cancer | David Church (Glasgow), Viktor Koelzer (Zurich) | analysis phase | in progress |
| 28 | How Ki-67 analysis differs in digital pathology platforms and the associations with survival, recurrance and stages of cancer | Matthew Macfarlane (Glasgow) | analysis phase | in progress |